Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04335136 |
|---|---|
| Brief Title: | Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 (APN01-COVID-19) |
| First Submitted : | April 1, 2020 |
| First Submitted that Met QC Criteria : | April 3, 2020 |
| First Posted : | April 6, 2020 |
| Results First Submitted : | June 7, 2021 |
| Results First Posted with QC Comments : | June 14, 2021 |
| Results First Submitted that Met QC Criteria : | July 29, 2021 |
| Results First Posted : | August 2, 2021 |
| Last Update Submitted that Met QC Criteria : | July 29, 2021 |
| Last Update Posted : | August 2, 2021 |